Cannabity Healthcare started its activity last January and has just closed its first round of capital increase in the country. $1,110,515 (€1,000,000) will allow the company to consolidate businesses in Spain and open up markets in Europe. They accumulated 400 orders and obtained a valuation of $310,830. Success lies in the improvement of patients who suffer from severe health conditions.
Thanks to the contribution of small investors, Cannabity Healthcare closed the Minimal Viable Product (MVP) from 2019 with excellent metrics and is already preparing to face its second round of capital increase for the beginning of 2020.
$1,110,515 (€1,000,000) will allow it to consolidate businesses in Spain and open up markets in Europe.
Cannabity Healthcare receives positive financial results
The good results of the MVP have made it possible for Cannabity Healthcare to accumulate more than 400 orders, with a turnover of more than $24,429 (€22,000). Which means an average ticket of just over $59 (€54).
This, together with the investment strategy set out in Capture Marketing, allows the platform to obtain results in terms of CPA (cost per acquisition) of $28 (€26), which, together with the forecast of a long LTV (lifetime value), makes it a very promising and rapidly scalable reality.
After this first capital increase, Cannabity Healthcare obtained a capital evaluation of $310,830 (€280,000).
Beyond numbers and statistics, the success of Cannabity Healthcare lies in the fact that patients who suffer from insomnia, stress, anxiety, chronic pain, skin problems, epilepsy or cancer, notice a remarkable improvement in their quality of everyday life.
Cannabity Healthcare focuses on medical patients
In only six months, Cannabity has positioned itself as a global meeting point for therapeutic cannabis thanks to the advice and practical information offered by the platform to its users.
They are backed by more than two years of research by its founders, who have been working hand in hand with medical specialists and other professionals in the sector to discuss the advantages of the cannabis plant for therapeutic purposes.
All this so that the patient can find a space of information in which to inform, manage and share their illness or disease, and allow themselves to lead a healthier life thanks to the benefits of medical cannabis.
Cannabity Healthcare is formed by a team of professionals specialized in the areas of marketing, sales, communication, scientific research, and technology.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Hemp.im, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in Comunicae, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.